Rallybio Corporation (RLYB)
USD 0.98
(-5.22%)
USD 0.98
(-5.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 150 Thousand | 167 Thousand | 109 Thousand | 62.03 Thousand | 26.34 Thousand |
| Gross Profit | -150 Thousand | -167 Thousand | -109 Thousand | -62.03 Thousand | -26.34 Thousand |
| Operating Expenses | 78.93 Million | 67.88 Million | 45.64 Million | 25.3 Million | 17.64 Million |
| Selling, General and Administrative Expenses | 25.38 Million | 27.19 Million | 18.73 Million | 7.67 Million | 6.27 Million |
| Research and Development Expenses | 53.54 Million | 40.68 Million | 26.9 Million | 17.63 Million | 11.36 Million |
| Other Expenses | - | 342 Thousand | 96 Thousand | 241 Thousand | 24 Thousand |
| Cost and Expenses | 78.93 Million | 67.88 Million | 45.64 Million | 25.3 Million | 17.64 Million |
| Operating Income | -78.93 Million | -67.88 Million | -45.64 Million | -25.3 Million | -17.64 Million |
| Interest Expense | - | - | 10 Thousand | 49 Thousand | 39 Thousand |
| Income Tax Expense | -2.04 Million | 908 Thousand | 1.5 Million | -15 Thousand | 166 Thousand |
| Earnings before Tax | -74.56 Million | -65.57 Million | -45.5 Million | -24.94 Million | -17.46 Million |
| Net Income | -74.56 Million | -66.48 Million | -47.01 Million | -24.92 Million | -17.62 Million |
| Earnings Per Share Basic | -1.84 | -2.09 | -1.46 | -0.78 | -0.55 |
| Earnings Per Share Diluted | -1.84 | -2.09 | -1.46 | -0.78 | -0.55 |
| Weighted Average Shares Outstanding | 40.44 Million | 31.82 Million | 32.12 Million | 32.12 Million | 32.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.44 Million | 31.82 Million | 32.12 Million | 32.12 Million | 32.12 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -72.37 Million | -65.41 Million | -45.38 Million | -24.82 Million | -17.39 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 299 Thousand | - | - | 228 Thousand | - | - |
| Cost of Revenue | 34 Thousand | 35 Thousand | 150 Thousand | 36 Thousand | 37 Thousand | 38 Thousand |
| Gross Profit | 265 Thousand | -35 Thousand | -150 Thousand | 192 Thousand | -37 Thousand | -38 Thousand |
| Operating Expenses | 17.3 Million | 19.75 Million | 78.78 Million | 21.07 Million | 19.36 Million | 20.08 Million |
| Selling, General and Administrative Expenses | 4.38 Million | 6.85 Million | - | 5.18 Million | 6.07 Million | 6.95 Million |
| Research and Development Expenses | 12.91 Million | 12.9 Million | - | 15.88 Million | 13.28 Million | 13.13 Million |
| Other Expenses | 143 Thousand | 167 Thousand | - | 35 Thousand | 92 Thousand | 62 Thousand |
| Cost and Expenses | 17.33 Million | 19.78 Million | 78.93 Million | 21.11 Million | 19.36 Million | 20.08 Million |
| Operating Income | -17.03 Million | -19.78 Million | -78.93 Million | -21.11 Million | -19.36 Million | -20.08 Million |
| Interest Expense | - | - | - | 1.65 Million | - | - |
| Income Tax Expense | 487 Thousand | 685 Thousand | 2.04 Million | 613 Thousand | -37 Thousand | 217 Thousand |
| Earnings before Tax | -15.74 Million | -18.34 Million | -72.52 Million | -19.62 Million | -18.37 Million | -18.41 Million |
| Net Income | -16.23 Million | -19.02 Million | -74.56 Million | -20.24 Million | -18.37 Million | -18.63 Million |
| Earnings Per Share Basic | -0.37 | -0.47 | - | -0.50 | -0.45 | -0.46 |
| Earnings Per Share Diluted | -0.37 | -0.47 | - | -0.50 | -0.45 | -0.46 |
| Weighted Average Shares Outstanding | 44.12 Million | 40.77 Million | 40.44 Million | 40.63 Million | 40.53 Million | 40.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.12 Million | 40.77 Million | 40.44 Million | 40.63 Million | 40.53 Million | 40.36 Million |
| Gross Margin | 0.89 | - | - | 0.84 | - | - |
| EBIT Margin | -56.86 | - | - | -92.44 | - | - |
| Profit Margin | -54.30 | - | - | -88.78 | - | - |
| EBITDA | -17 Million | -19.75 Million | - | -21.07 Million | -19.36 Million | -20.08 Million |
| Earnings Before Tax Margin | -56.97 | - | - | -92.60 | - | - |
PBCRY
7865
TITA-B
GDR
4421
ACE